Half of drugs in experimentation are biotech. Greco (Assobiotec): A shared vision is crucial
Currently, 50% of the drugs in experimentation are biotechnological. Within a few years, eight out of 10 drugs will be biotech, with an exponential economic growth of the market, projected to increase from 485 billion euros in 2020 to 1.447 trillion euros in 2028. These are some of the figures that ...





